logo

MRK

Merck·NYSE
--
--(--)
--
--(--)
5.99 / 10
Netural

Comprehensive review: 6.0/10 score signifies fair fundamentals. Optimistic factors: Days sales outstanding and Cost of sales ratio (%), whereas limitations surface in Income tax / Total profit (%) and Operating revenue (YoY growth rate %). Resulting view: guarded.

Fundamental(5.99)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.01
Score2/3
Weight17.81%
1M Return9.81%
Days sales outstanding
Value56.91
Score3/3
Weight1.89%
1M Return1.30%
Profit-MV
Value-0.27
Score3/3
Weight21.79%
1M Return12.21%
PB-ROE
Value1.51
Score3/3
Weight26.03%
1M Return12.29%
Income tax / Total profit (%)
Value13.31
Score0/3
Weight-1.91%
1M Return-1.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value44.38
Score2/3
Weight-0.91%
1M Return-0.66%
Operating revenue (YoY growth rate %)
Value1.31
Score1/3
Weight-0.38%
1M Return-0.28%
Cost of sales ratio (%)
Value25.20
Score3/3
Weight1.11%
1M Return0.72%
Asset-MV
Value-0.53
Score1/3
Weight16.96%
1M Return8.51%
Cash-MV
Value0.15
Score3/3
Weight17.62%
1M Return9.70%
Is MRK fundamentally strong?
  • MRK scores 5.99/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 28.09% net margin, 16.68 P/E ratio, 5.87 P/B ratio, and 8.60% earnings growth, these metrics solidify its Netural investment rating.